The observed inverse correlation between the magnitude of changes in AACS expression with changes in concentration of metabolites in cluster-2A (Fig. S4-2a in the “Electronic Supplementary Material”) suggests that FASN inhibition by orlistat in NSCLC cells induces compensatory up-regulation of AACS to satisfy the increasing demand for FA. Here, FASN is linked to non-small cell lung carcinoma.